ZoMfG Zomfg ZOMFG!!!!

SuN

.:~**~.~**~.~**~:.
I've ben successfull in my submission to travel teh globes to 3rd world countieeeeeeees providing research and edumakationalz on safe drug use and blood borne virus PrEvEnTiOnZ....

ZOMFG ZOMFG ZOMFG ZOMFG ZOMFG ZOMFG ZOMFGZOMG ZOMFG ZOMFG

I am MoAr awesomer than I thunk!!
Fuck yeah, fuck yeaaaaaaaaaaaaaaaah!!!!

Ya'll can congradulate me with GrEeN Karmaz!!

kthnx
 

Cock

Let's be making sexy business
wHAT DOES THAT z STAND FOR?
 

FBI parte due

Folces Weard
Suid-Afrika? Kongo?

[YOUTUBE]MvvGEJ4Xgeg[/YOUTUBE]
 

SuN

.:~**~.~**~.~**~:.
North Africa, Mid East from the Levant across to Iran, including KSA; with Lebanon leading the charge in UN funded Harm Reduction targeted at injecting drug users.

They has a lil mobile van like teh russian one; than cruises amonst teh ghetos n aid camps; which I am vry excited to check out; they provide clean equipment; access to treatment and support and have nurses and doctors on board to manage emerging health issues and treat HIV with anti-virals.

Yay...tehn after this little fun tiems, im off to the jungles of PNG to hang with some tribesmen & day n' night dive the stunning coral reefs with whale sharks n' etc.

Fuck 2011 is going to be awesome!!!

http://en.wikipedia.org/wiki/North_Africa
 

FBI parte due

Folces Weard
My career path is taking me further and further away from being able to run off and spend a year in Tehran whenever I want to. Maybe I'll take five years off and spend them in the FFL shooting Darfurian refugees in the face.
 

SuN

.:~**~.~**~.~**~:.
& not mujadeen? damn i'd relish the opportunity to butcher those mofo's

Shame to hear of your career diversions...ur with gov yeah?
No chance of holding them to ransom of all the training and arabic studies to force thar hand?
 

SuN

.:~**~.~**~.~**~:.
lol

SOUTH AFRICA: "'Whoonga' Drug: A New Twist in South Africa's AIDS War"
Associated Press (11.20.10):: Donna Bryson

Drug users in South Africa's KwaZulu-Natal province are diverting antiretroviral pills intended for AIDS patients and mixing them in illicit concoctions to get high, authorities and health experts say. So far, the practice of smoking the ARV-laced mixture called "whoonga" has been limited to the eastern part of the province. AIDS and addiction specialists hope it does not spread.

KwaZulu-Natal police first noticed whoonga two or three years ago, when gangs began stealing ARVs from patients as they left hospitals, said Vincent Ndunge, a police spokesperson. Users initially smoked the crushed ARVs, but later began adding other substances, he said. Marijuana is one preferred component.

Some patients sell their ARVs for use in whoonga, and AIDS clinics also have been robbed, said Carol du Toit of South Africa's National Council on Alcoholism and Drug Dependence. Staff members of her private organization are seeing an increase in whoonga users, with many testing positive for heroin.

Whoonga users may be getting high from some other ingredient in the mix rather than from the ARVs, suggests Dr. Njabulo Mabaso, an AIDS expert. Drug dealers have been suspected of cutting their whoonga with many substances, including soap powder and rat poison, to stretch their supply. There is no evidence that ARVs are addictive per se or enhance the marijuana high.

"We are seeing the use of whoonga in communities and it's very widespread," said Lihle Dlamini of the Treatment Action Campaign advocacy group. Dealers "are taking this treatment that is supposed to assist people living with HIV and abusing it," she said.

"The main problem is unemployment," said Thokozani Sokhulu, who founded "Project Whoonga" this year to help rehabilitate users and help them find jobs or training. "It's when they're hanging around all day with nothing to do - that's when they get hooked."
 

FBI parte due

Folces Weard
^That's old news, innit?

I definitely still like the idea of working for the government in some godforsaken hellhole most people won't touch, especially when a lot of the time being a FSO can mean hella partying and working on making sure the locals keep on being OK with there being a massive military base in the area, but the acceptance rate for those exams is like 2%.

Like, I definitely have a decent chance of beating those odds, but I'm also considering other options, like whoring myself out to The Jew and writing threatening letters for a living. Arabic is valuable, but it's not that rare among people who intend to work for the State Department as a career.
 

SuN

.:~**~.~**~.~**~:.
yeah it is old news, just a lil lulzy is all.

u cant do the whole 'u invested in mah arabic, use it or have it used against u' kinda deal?
Mercenary/free agent type stuff is the fucking shitnitz; hope ur planzors goes well FBI; nations without governments rock!
 

SuN

.:~**~.~**~.~**~:.
A position statement from the International Harm Reduction Association

Harm reduction refers to policies, programmes and practices that aim to reduce the harms associated with the use of psychoactive drugs in people unable or unwilling to stop. The defining features are the focus on the prevention of harm, rather than on the prevention of drug use itself, and the focus on people who continue to use drugs.

Harm reduction began to be discussed frequently after the threat of HIV spreading among and from injecting drug users was first recognised. However, similar approaches have long been used in many other contexts for a wide range of drugs.

Harm reduction complements approaches that seek to prevent or reduce the overall level of drug consumption. It is based on the recognition that many people throughout the world continue to use psychoactive drugs despite even the strongest efforts to prevent the initiation or continued use of drugs. Harm reduction accepts that many people who use drugs are unable or unwilling to stop using drugs at any given time. Access to good treatment is important for people with drug problems, but many people with drug problems are unable or unwilling to get treatment.

Furthermore, the majority of people who use drugs do not need treatment. There is a need to provide people who use drugs with options that help to minimise risks from continuing to use drugs, and of harming themselves or others. It is therefore essential that harm reduction information, services and other interventions exist to help keep people healthy and safe. Allowing people to suffer or die from preventable causes is not an option. Many people who use drugs prefer to use informal and non-clinical methods to reduce their drug consumption or reduce the risks associated with their drug use.

This short statement sets out the main characteristics of harm reduction. This statement is designed to be relevant to all psychoactive drugs including controlled drugs, alcohol, tobacco and pharmaceutical drugs. The specific harm reduction interventions may differ for different drugs.

Definition

‘Harm Reduction’ refers to policies, programmes and practices that aim primarily to reduce the adverse health, social and economic consequences of the use of legal and illegal psychoactive drugs without necessarily reducing drug consumption. Harm reduction benefits people who use drugs, their families and the community.
The harm reduction approach to drugs is based on a strong commitment to public health and human rights.

Targeted at risks and harms

Harm reduction is a targeted approach that focuses on specific risks and harms. Politicians, policymakers, communities, researchers, frontline workers and people who use drugs should ascertain:

*What are the specific risks and harms associated with the use of specific psychoactive drugs?
*What causes those risks and harms?
*What can be done to reduce these risks and harms?

Harm reduction targets the causes of risks and harms. The identification of specific harms, their causes, and decisions about appropriate interventions requires proper assessment of the problem and the actions needed. The tailoring of harm reduction interventions to address the specific risks and harms must also take into account factors which may render people who use drugs particularly vulnerable, such as age, gender and incarceration.

Evidence based and cost effective

Harm reduction approaches are practical, feasible, effective, safe and cost-effective. Harm reduction has a commitment to basing policy and practice on the strongest evidence available. Most harm reduction approaches are inexpensive, easy to implement and have a high impact on individual and community health. In a world where there will never be sufficient resources, benefit is maximised when low-cost/high-impact interventions are preferred over high-cost/low-impact interventions.

Incremental

Harm reduction practitioners acknowledge the significance of any positive change that individuals make in their lives. Harm reduction interventions are facilitative rather than coercive, and are grounded in the needs of individuals. As such, harm reduction services are designed to meet people’s needs where they currently are in their lives. Small gains for many people have more benefit for a community than heroic gains achieved for a select few. People are much more likely to take multiple tiny steps rather than one or two huge steps.

The objective of harm reduction in a specific context can often be arranged in a hierarchy with the more feasible options at one end (eg measures to keep people healthy) and less feasible but desirable options at the other end. Abstinence can be considered a difficult to achieve but desirable option for harm reduction in such a hierarchy. Keeping people who use drugs alive and preventing irreparable damage is regarded as the most urgent priority while it is acknowledged that there may be many other important priorities.

Dignity and compassion

Harm reduction practitioners accept people as they are and avoid being judgemental. People who use drugs are always somebody’s son or daughter, sister or brother or father or mother. This compassion extends to the families of people with drug problems and their communities. Harm reduction practitioners oppose the deliberate stigmatisation of people who use drugs. Describing people using language such as ‘drug abusers’, ‘a scourge’, ‘bingers’, ‘junkies’, ‘misusers’, or a ‘social evil’ perpetuates stereotypes, marginalises and creates barriers to helping people who use drugs. Terminology and language should always convey respect and tolerance.

Universality and interdependence of rights

Human rights apply to everyone. People who use drugs do not forfeit their human rights, including the right to the highest attainable standard of health, to social services, to work, to benefit from scientific progress, to freedom from arbitrary detention and freedom from cruel inhuman and degrading treatment. Harm reduction opposes the deliberate hurts and harms inflicted on people who use drugs in the name of drug control and drug prevention, and promotes responses to drug use that respect and protect fundamental human rights.

Challenging policies and practices that maximise harm

Many factors contribute to drug-related risks and harms including the behaviour and choices of individuals, the environment in which they use drugs, and the laws and policies designed to control drug use. Many policies and practices intentionally or unintentionally create and exacerbate risks and harms for drug users. These include: the criminalisation of drug use, discrimination, abusive and corrupt policing practices, restrictive and punitive laws and policies, the denial of life-saving medical care and harm reduction services, and social inequities. Harm reduction policies and practice must support individuals in changing their behaviour. But it is also essential to challenge the international and national laws and policies that create risky drug using environments and contribute to drug related harms.

Transparency, accountability and participation

Practitioners and decision makers are accountable for their interventions and decisions, and for their successes and failures. Harm reduction principles encourage open dialogue, consultation and debate. A wide range of stakeholders must be meaningfully involved in policy development and programme implementation, delivery and evaluation. In particular, people who use drugs and other affected communities should be involved in decisions that affect them.
 

SuN

.:~**~.~**~.~**~:.
History and Founders

In 1990, Liverpool, England hosted the 1st International Conference on the Reduction of Drug Related Harm. The city was one of the first to open needle exchanges and had attracted hundreds of visitors each year who wanted to learn about the Mersey Harm Reduction Model. The conference was a way of dealing with this interest and the volume of visitors and it was a huge success. Accordingly, the following year, the 2nd International Conference on the Reduction of Drug Related Harm took place in Barcelona and a movement soon developed around this conference – spreading the principles behind the harm reduction approach, sharing knowledge and experiences from around the world and promoting the growing scientific evidence that supported this approach.

In 1995, Ernie Drucker outlined an idea he had for an International Harm Reduction Association, which would enable knowledge sharing and communication all year round and between conferences. This new organisation would advocate around the world for sensible policies on drugs. The following year, the birth of IHRA was announced at the 7th International Conference on the Reduction of Drug Related Harm in Hobart, Tasmania. The 10 founding members became the first Executive Committee and, under the leadership of Pat O’Hare, held their first meeting at the 8th International Conference on the Reduction of Drug Related Harm in Paris.

Initially, IHRA existed to support the development of harm reduction, enable knowledge exchange and provide a supportive environment for harm reduction workers. In time, however, the organisation (and the field in general) grew and the focus shifted to getting harm reduction on international political agendas. Over the next few years, harm reduction became more global, increasingly professional and backed by an ever-increasing scientific evidence-base.

IHRA has become the leading organisation promoting harm reduction approaches to all psychoactive substances on a global basis. The initial contributions from the 10 founder members must never be forgotten, however, as they were fundamental to the organisation’s creation.
 

SuN

.:~**~.~**~.~**~:.
Patrick J. Aeberhard

Patrick J. Aeberhard currently lives in Paris. For over 25 years, he has worked to promote and defend democratic institutions, human rights and humanitarian action for the victims of catastrophes. Patrick has previously worked with the International Committee of the Red Cross and co-founded Médecins sans Frontières (MSF) and Médecins du Monde (MDM), of which he was President until 1989 and is currently an Honorary President. He has been an advisor to the French Government and a member of various French Governmental Committees. As well as being a founder member of IHRA, Patrick directed the 8th International Conference on the Reduction of Drug Related Harm (Paris, 1997).

Patrick is a consultant in Cardiology and currently runs the Cardiac Rehabilitation Center in the Centre Cardiologique du Nord, Saint-Denis, Paris (a post he has held since 1980). He is also special adviser to Bernard Kouchner, the former French Minister of Humanitarian Affairs. In 1969, Patrick received the Silver Cross of the French Red Cross and has also been awarded Le Chevalier de la Légion d'Honneur in 1993.
 

SuN

.:~**~.~**~.~**~:.
Ernst Buning

Ernst Buning has been working in the area of public health and substance use since 1977 and was instrumental in the development of harm reduction policies in the Netherlands in the early 1980s. Ernst was re-elected onto the IHRA Executive Committee in 2002 where he currently serves as the Chair.
 

SuN

.:~**~.~**~.~**~:.
Dave Burrows

Dave Burrows has worked on the topics of HIV/AIDS and substance use since 1987. Based in Sydney, Australia, Dave wrote and edited groundbreaking publications and materials about drug use and HIV/AIDS for a variety of audiences (such as medical professionals, substance use practitioners and the general public). In 1991 he joined a leading community-based agency and worked on educational HIV prevention campaigns directed at injecting drug users in Sydney. Dave later became general manager of the agency and went on to join the AIDS Projects Management Group in 1994, progressing to Deputy Director and then Director.

Since 1996, Dave has worked as a consultant on HIV/AIDS and drug use in over 30 countries. He has assisted global organisations (such as the UN), governmental aid agencies and NGOs at all levels. In recent years, Dave has been working on the broader issues related to HIV/AIDS and has designed programmes targeting the general community as well as specific groups such as medical professionals, young people, men who have sex with men and commercial sex workers.
 

SuN

.:~**~.~**~.~**~:.
Ernie Drucker

From 1970 – 1990, Ernie Drucker was the founding Director of a 1000-patient drug treatment program in the Bronx, New York. He has been a leading researcher on HIV/AIDS and drug addiction for over 15 years and has written over 100 scientific articles and book chapters. He is currently the Editor in Chief for the internationally respected “Addiction Research and Theory” journal as well as the Internet-based “Harm Reduction Journal”. As well as being a founder member of IHRA, Ernie was also Chairman of Doctors of the World / USA (1993- 1997) and a senior Soros Justice Fellow (2004-2005).

Ernest Drucker is currently Professor of Epidemiology and Social Medicine and Professor of Psychiatry at the Montefiore Medical Center, Albert Einstein College of Medicine in New York City. His research examines AIDS, drug use, and drug policy in the USA and in other countries. He is a licensed Clinical Psychologist in New York and active in drug law reform and human rights.
 

SuN

.:~**~.~**~.~**~:.
Fabio Mesquita

Fabio Mesquita is a physician from Brazil. He has a PhD in Public Health and previously ran the STD/AIDS Program of the City of Sao Paulo Health Department (the third most senior Governmental position on AIDS in Brazil). Fabio was instrumental in introducing harm reduction to Brazil and Latin America and first tried to introduce a needle exchanges in Sao Paulo in 1989 (in order to control what was, at that time, the biggest epidemic of HIV among injecting drug users in Brazil). As well as IHRA, Fabio is also the founder of the Institute for AIDS Studies and Research (IEPAS), the Latin American Harm Reduction Network (RELARD) and the Brazilian Harm Reduction Network (REDUC). His work has been recognised with various awards including IHRA’s International Rolleston Award.

Fabio is currently the Harm Reduction Advisor for the Indonesian HIV/AIDS Prevention and Care Project, an AusAID project in Indonesia, South East Asia
 

SuN

.:~**~.~**~.~**~:.
Diane Riley

Diane Riley has a PhD in Psychophysiology from the University of Toronto and her post-doctoral research was at the Addiction Research Foundation in Toronto. For more than 20 years, Diane has been a leading researcher in the socio- and bio-behavioural effects of drug use and has worked in Australia, Canada, England, Papua-New Guinea, Sweden, the USA and Central Asia. Her publications are in the areas of drug policy and treatment, HIV/AIDS, harm reduction, learning theory, psychophysiology and drug education. Diane has worked with community groups to set up the first bleach kit programs and syringe exchanges in Toronto and, from 1990 to 1996, was Senior Policy Analyst at the Canadian Centre on Substance Abuse. As well as IHRA, Diane was also a founding member of the Canadian Foundation for Drug Policy. From 1999 – 2003, she also represented North American NGOs on the UNAIDS Programme Coordinating Board.

Diane is currently a policy analyst for the Canadian Foundation for Drug Policy and her work involves reviewing drug policies and programmes around the world. She is a member of the Faculty of Medicine at the University of Toronto and teaches courses on harm reduction at York University in Toronto.
 

SuN

.:~**~.~**~.~**~:.
Alex Wodak

Alex Wodak trained as a physician and, since 1982, has been Director of the Alcohol and Drug Service at St. Vincent's Hospital in Sydney, Australia. Dr Wodak and his colleagues helped to establish the National Drug and Alcohol Research Centre, the Australian Society of HIV Medicine, Australia's first (pre-legal) needle exchange programme and Australia’s first (pre-legal) medically supervised injecting centre. Dr. Wodak is currently the President of the Australian Drug Law Reform Foundation and is a member of several state and national committees. He often works in developing countries to assist efforts to control HIV infection among injecting drug users
 

SuN

.:~**~.~**~.~**~:.
ANA MIN BEIRUT!

I love Beirut because she is the underdog and manages always to win. Through the rubble she emerges again and again every time more beautiful than before.

I love Beirut because I can read the “Agenda Culturel” while eating “Fatteh bi Laban” at Abou André

I love Beirut because of the American saxophonist who plays twelve variations on “Bint Al Chalabiya” as if he just finished a music course with Assi El Rahbani.
I love Beirut because of the oud player who makes Ravel quiver of excitement in his grave hearing the oriental rendition of Boléro.

I love Beirut because the bigger its temples of worship get the more secular its population becomes.

I love Beirut because at Masrah Al Madina a group of recently high school graduate females acted out a play about female masturbation called “The Secret Life of a Woman” (Hayat el Mar’a al Sirriya) and at the end of the play they distributed flyers about the subject to all the audience, male and female.
In any other Arab country, running such a play would bring the dictator down.

I love Beirut because you see the “frenchy-coocoo” chick, along with the pierced nose left winger WOUMAAAN, the veiled religious one with a ton of makeup on, and the slut who is two inches short of wearing a fig leaf as a business suit.

I love Beirut because of the BMW driving, cigar smoking, gel wearing prick who thinks he makes the New York Stock Exchange tick.
I love Beirut because of the bearded, pony-tailed artist/journalist who writes for left wing publications.
I love Beirut because of the guys who claim they are Lebanese university students and try to sell you scented trees for your car during traffic stops. These guys wouldn’t know a book if it drops on their head.
I love Beirut because of the nerdy types Engineer/Software developer dudes who are working on the first water fueled engine or the next Google search engine.

I love Beirut because of the “full-of-shit” politicians who make watching the news hilarious.

I love Beirut because of the sunsets at Raouche. The People on Corniche.

I love Beirut because they have delivery service for practically anything. Anything.
 

SuN

.:~**~.~**~.~**~:.
[YOUTUBE]g1uDyqPYLVM[/YOUTUBE]
 
Top